{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:07:13Z","timestamp":1772248033613,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s11060-008-9642-1","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T08:13:19Z","timestamp":1214554399000},"page":"125-132","source":"Crossref","is-referenced-by-count":20,"title":["Tissue transgluaminase 2 expression in meningiomas"],"prefix":"10.1007","volume":"90","author":[{"given":"Liya","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Behdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaitan","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Higashikubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"9642_CR1","first-page":"583","volume-title":"Greenfield\u2019s neuropathology","author":"PL Lantos","year":"1997","unstructured":"Lantos PL, Vandenberg SR, Kleihues P (1997) Tumours of the nervous system. In: Graham DI, Lantos PL (eds) Greenfield\u2019s neuropathology, 6th edn. Arnold, London, pp 583\u2013879","edition":"6"},{"key":"9642_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1227\/01.NEU.0000068730.76856.58","volume":"53","author":"M Nakamura","year":"2003","unstructured":"Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgery 53:62\u201371","journal-title":"Neurosurgery"},{"key":"9642_CR3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2004.09.033","volume":"62","author":"AW Jensen","year":"2005","unstructured":"Jensen AW, Brown PD, Pollock BE et al (2005) Gamma knife radiosurgery of radiation-induced intracranials: local control, outcomes, and complications. Int J Radiat Oncol Biol Phys 62:32\u201337","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9642_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.coc.0000139958.88481.5c","volume":"28","author":"TS Katz","year":"2005","unstructured":"Katz TS, Amdur RJ, Yachnis AT, Mendenhall WM, Morris CG (2005) Pushing the limits of radiotherapy for atypical and malignant meningioma. Am J Clin Oncol 28:70\u201374","journal-title":"Am J Clin Oncol"},{"key":"9642_CR5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1026770624783","volume":"49","author":"HB Newton","year":"2000","unstructured":"Newton HB, Slivka MA, Stevens C (2000) Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 49:165\u2013170","journal-title":"J Neurooncol"},{"key":"9642_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","volume":"4","author":"L Lorand","year":"2003","unstructured":"Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140\u2013156","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9642_CR7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","volume":"27","author":"L Fesus","year":"2002","unstructured":"Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534\u2013539","journal-title":"Trends Biochem Sci"},{"key":"9642_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20021234","volume":"368","author":"M Griffin","year":"2002","unstructured":"Griffin M, Casadio R, Bergamini CM (2002) Transglutaminases: nature\u2019s biological glues. Biochem J 368:377\u2013396","journal-title":"Biochem J"},{"key":"9642_CR9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.7911253","volume":"264","author":"H Nakaoka","year":"1994","unstructured":"Nakaoka H, Perez DM, Baek KJ et al (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264:1593\u20131596","journal-title":"Science"},{"issue":"43","key":"9642_CR10","doi-asserted-by":"crossref","first-page":"42604","DOI":"10.1074\/jbc.M303303200","volume":"278","author":"EAM Verderio","year":"2003","unstructured":"Verderio EAM, Telci D, Okoye A, Melino G, Griffin M (2003) A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278(43):42604\u201342614","journal-title":"J Biol Chem"},{"key":"9642_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1535-7163.MCT-04-0328","volume":"4","author":"L Yuan","year":"2005","unstructured":"Yuan L, Choi K, Khosla C, Zheng X, Higashikubo R, Chicoine MR, Rich KM (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastoma. Mol Cancer Ther 4:293\u2013302","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"9642_CR12","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/sj.onc.1210048","volume":"26","author":"L Yuan","year":"2007","unstructured":"Yuan L, Siegel M, Choi K, Khosla C, Miller CR, Jackson EN, Piwnica-Worms D, Rich KM (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26(18):2563\u20132573","journal-title":"Oncogene"},{"issue":"4","key":"9642_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chembiol.2005.02.007","volume":"12","author":"K Choi","year":"2005","unstructured":"Choi K, Siegel M, Piper JL et al (2005) Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol 12(4):469\u2013475","journal-title":"Chem Biol"},{"key":"9642_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"W Lee","year":"1990","unstructured":"Lee W (1990) Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27:389\u2013396","journal-title":"Neurosurgery"},{"key":"9642_CR15","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1046\/j.1471-4159.2000.0751951.x","volume":"75","author":"M Lesort","year":"2000","unstructured":"Lesort M, Tucholski J, Zhang J, Johnson GVW (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in\u00a0situ. J Neurochem 75:1951\u20131961","journal-title":"J Neurochem"},{"key":"9642_CR16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1165\/rcmb.2002-0114OC","volume":"28","author":"N Martinet","year":"2003","unstructured":"Martinet N, Bonnard L, Regnault V et al (2003) In\u00a0vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer. Am J Respir Cell Mol Biol 28:428\u2013435","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9642_CR17","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1158\/1078-0432.CCR-04-1107","volume":"10","author":"K Mehta","year":"2004","unstructured":"Mehta K, Fok J, Miller FR, Koul D, Sahin AA (2004) Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 10:8068\u20138076","journal-title":"Clin Cancer Res"},{"key":"9642_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1014461832403","volume":"71","author":"JS Chen","year":"2002","unstructured":"Chen JS, Argarwal N, Mehta K (2002) Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat 71:237\u2013247","journal-title":"Breast Cancer Res Treat"},{"key":"9642_CR19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/94.21.1652-b","volume":"94","author":"K Mehta","year":"2002","unstructured":"Mehta K, Devarajan E, Chen J, Multani A, Pathak S (2002) Multidrug-resistant MCF-7 cells: an identiy crisis. J Natl Cancer Inst 94:1652\u20131654","journal-title":"J Natl Cancer Inst"},{"key":"9642_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1568009023333872","volume":"2","author":"Y Liang","year":"2002","unstructured":"Liang Y, McDonnell S, Clynes M (2002) Examining the relationship between cancer invasion\/metastasis and drug resistance. Curr Cancer Drug Targets 2:257\u2013277","journal-title":"Curr Cancer Drug Targets"},{"key":"9642_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcb.240560108","volume":"56","author":"RS Kerbel","year":"1994","unstructured":"Kerbel RS, Kabayashi H, Graham CH (1994) Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J Cell Biochem 56:37\u201347","journal-title":"J Cell Biochem"},{"key":"9642_CR22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bbrc.2005.06.039","volume":"333","author":"F Qian","year":"2005","unstructured":"Qian F, Zhang ZC, Wu XF, Li YP, Xu Q (2005) Interaction between integrin \u03b15 and fibronectin is required for metastasis of B16F10 melanoma cells. Biochem Biophys Res Comm 333:1269\u20131275","journal-title":"Biochem Biophys Res Comm"},{"key":"9642_CR23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.148.4.825","volume":"148","author":"SS Akimov","year":"2000","unstructured":"Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825\u2013838","journal-title":"J Cell Biol"},{"key":"9642_CR24","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1242\/jcs.114.16.2989","volume":"114","author":"SS Akimov","year":"2001","unstructured":"Akimov SS, Belkikn AM (2001) Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGF\u03b2-dependent matrix deposition. J Cell Sci 114:2989\u20133000","journal-title":"J Cell Sci"},{"key":"9642_CR25","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/emboj\/16.10.2783","volume":"16","author":"A Khwaja","year":"1997","unstructured":"Khwaja A, Rodriguez-Viciana PK, Wennstrom S, Warne PH, Downward J (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B\/Akt cellular survival pathway. EMBO J 16:2783\u20132793","journal-title":"EMBO J"},{"key":"9642_CR26","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1128\/MCB.17.8.4406","volume":"17","author":"WG King","year":"1997","unstructured":"King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS (1997) Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1\/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17:4406\u20134418","journal-title":"Mol Cell Biol"},{"issue":"50","key":"9642_CR27","doi-asserted-by":"crossref","first-page":"50402","DOI":"10.1074\/jbc.M307627200","volume":"278","author":"M Fornaro","year":"2003","unstructured":"Fornaro M, Plescia J, Cheang S et al (2003) Fibronectin protects prostate cancer cells from tumor necrosis factor-\u03b1-induced apoptosis via the AKT\/survivin pathway. J Biol Chem 278(50):50402\u201350411","journal-title":"J Biol Chem"},{"key":"9642_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta SR, Dudek H, Tao T et al (1997) Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 91:231\u2013241","journal-title":"Cell"},{"key":"9642_CR29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00432-002-0343-4","volume":"128","author":"DA Tan","year":"2002","unstructured":"Tan DA, Teo WL, Smith DR (2002) Expression of survivin in primary glioblastoma. J Cancer Res Clin Oncol 128:302\u2013306","journal-title":"J Cancer Res Clin Oncol"},{"key":"9642_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95\u2013102","journal-title":"Trends Biochem Sci"},{"key":"9642_CR31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","volume":"9","author":"SM Frisch","year":"1997","unstructured":"Frisch SM, Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9:701\u2013706","journal-title":"Curr Opin Cell Biol"},{"key":"9642_CR32","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti FG, Ruoslahti E (1999) Integren signaling. Science 285:1028\u20131032","journal-title":"Science"},{"key":"9642_CR33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev 5:816\u2013826","journal-title":"Nat Rev"},{"key":"9642_CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.7716514","volume":"268","author":"EA Clarck","year":"1995","unstructured":"Clarck EA, Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268:233\u2013239","journal-title":"Science"},{"key":"9642_CR35","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","volume":"93","author":"JS Damiano","year":"1999","unstructured":"Damiano JS, Cress AE, Hezlehurst LA, Shtil AA, Dalton WS (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93:1658\u20131667","journal-title":"Blood"},{"key":"9642_CR36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/09553000310001610240","volume":"79","author":"MA Blases","year":"2003","unstructured":"Blases MA, Plasswilm L et al (2003) Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumor and normal cells in\u00a0vitro. Int J Radiat Biol 79:709\u2013720","journal-title":"Int J Radiat Biol"},{"key":"9642_CR37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005072-198605000-00012","volume":"45","author":"JT Rutka","year":"1986","unstructured":"Rutka JT, Giblin J, Dougherty DV, McCulloch JR, DeArmond SJ, Rosenblum ML (1986) An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol 45:285\u2013303","journal-title":"J Neuropathol Exp Neurol"},{"key":"9642_CR38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00688590","volume":"66","author":"G Bellon","year":"1985","unstructured":"Bellon G, Caulet T, Cam Y et al (1985) Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol 66:245\u2013252","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-008-9642-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-008-9642-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T17:59:08Z","timestamp":1631469548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-008-9642-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9642"],"URL":"https:\/\/doi.org\/10.1007\/s11060-008-9642-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}